New Lumos AI platform targets precision in mental health drugs
Headlamp Health has launched Lumos AI®, a new decision-support platform designed to bring greater precision to neuroscience drug development.
List view / Grid view
Headlamp Health has launched Lumos AI®, a new decision-support platform designed to bring greater precision to neuroscience drug development.
A new deep-learning method could enhance therapeutic devices for people with neurological or mental health conditions.
An AI system could be used to observe how physical constraints shape brains and impact people with cognitive difficulties.
Researchers at the University of San Francisco have suggested how advances in EEG brain scanners could help to diagnose brain conditions earlier...
24 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Professor Mark Baker, Director of Guidelines at NICE, said, “Having a baby is a time of huge change and any woman can find herself needing help...